BULLISHWHALES
BullishWhales · Analysts · Analyst Profile
BW Score Rank#151 of 347

Joseph Stringer

Needham · Equity Research Analyst
ProvisionalRating since 2021No new ratings since Jun 2025

Analyst rating accuracy & track record

Joseph Stringer is an equity research analyst at Needham. Bullish Whales has scored 53 of their stock calls across 7 companies. Their picks beat their sector 35% of the time over the next 12 months, and their price targets were reached 21% of the time within a year.

Win % vs sector
35%
PT Hit % (12mo)
21%
Avg sector-excess
−4.9%
Scored calls
53
Tickers
7
Tier
Provisional

Track record

Bullish Whales has scored 53 of Joseph Stringer's stock calls across 7 companies, dating back to 2021. Their rated stocks beat their own sector 35% of the time over the next 12 months. On a typical call, a Stringer pick returned −4.9% more than its sector over the following year.

Of the scored calls, 53 were bullish (Buy). Most of their coverage sits in Healthcare. Every number on this page is an estimate from our own data. It is for education only and is not investment advice.

Coverage & ratings

Ratings & price targets

StockRatingPrice targetRated12-mo vs sectorPT hit
PHATPhathom Pharmaceuticals Inc
Buy$28.00Jun 2025−2.6%Miss
VIRVir Biotechnology Inc
Buy$14.00May 2025+87.2%Miss
ANNXAnnexon Inc
Buy$11.00May 2025+193.7%Miss
VIRVir Biotechnology Inc
Buy$14.00May 2025+87.4%Miss
APLSApellis Pharmaceuticals Inc
Buy$29.00May 2025+120.5%Hit
PHATPhathom Pharmaceuticals Inc
Buy$28.00Apr 2025+215.3%Miss
PHATPhathom Pharmaceuticals Inc
Buy$28.00Apr 2025+194.9%Miss
STOKStoke Therapeutics Inc
Buy$22.00Apr 2025+426.4%Hit
PCVXVaxcyte Inc
Buy$90.00Apr 2025+85.3%Miss
PHATPhathom Pharmaceuticals Inc
Buy$28.00Apr 2025+122.2%Miss
PCVXVaxcyte Inc
Buy$90.00Apr 2025+69.4%Miss
STOKStoke Therapeutics Inc
Buy$22.00Mar 2025+273.6%Hit
PHATPhathom Pharmaceuticals Inc
Buy$28.00Mar 2025+106.8%Miss
ANNXAnnexon Inc
Buy$16.00Mar 2025+95.8%Miss
VIRVir Biotechnology Inc
Buy$19.00Feb 2025−1.1%Miss
PCVXVaxcyte Inc
Buy$140.00Feb 2025−28.0%Miss
STOKStoke Therapeutics Inc
Buy$22.00Feb 2025+223.5%Hit
PCVXVaxcyte Inc
Buy$14.00Feb 2025−44.2%Hit
PHATPhathom Pharmaceuticals Inc
Buy$28.00Jan 2025+105.4%Miss
PHATPhathom Pharmaceuticals Inc
Buy$28.00Dec 2024+71.6%Miss
VIRVir Biotechnology Inc
Buy$19.00Nov 2024−27.0%Miss
ANNXAnnexon Inc
Buy$16.00Nov 2024−53.5%Miss
PCVXVaxcyte Inc
Buy$140.00Nov 2024−59.0%Miss
APLSApellis Pharmaceuticals Inc
Buy$60.00Nov 2024−31.0%Miss
VIRVir Biotechnology Inc
Buy$19.00Nov 2024−40.4%Miss
PHATPhathom Pharmaceuticals Inc
Buy$26.00Sep 2024−27.8%Miss
PHATPhathom Pharmaceuticals Inc
Buy$26.00Sep 2024−19.8%Miss
PCVXVaxcyte Inc
Buy$140.00Sep 2024−59.5%Miss
PHATPhathom Pharmaceuticals Inc
Buy$26.00Aug 2024−16.2%Miss
PHATPhathom Pharmaceuticals Inc
Buy$26.00Aug 2024−6.2%Miss
PHATPhathom Pharmaceuticals Inc
Buy$26.00Aug 2024−8.7%Miss
ANNXAnnexon Inc
Buy$16.00Aug 2024−43.0%Miss
PHATPhathom Pharmaceuticals Inc
Buy$26.00Aug 2024−2.9%Miss
PCVXVaxcyte Inc
Buy$95.00Aug 2024−47.2%Hit
PCVXVaxcyte Inc
Buy$95.00Jun 2024−52.3%Hit
ANNXAnnexon Inc
Buy$16.00Jun 2024−57.1%Miss
TVRDTvardi Therapeutics, Inc.
Buy$5.00May 2024+28.7%Miss
TVRDTvardi Therapeutics, Inc.
Buy$5.00May 2024+6.8%Miss
ANNXAnnexon Inc
Buy$16.00May 2024−56.7%Miss
ANNXAnnexon Inc
Buy$16.00Apr 2024−75.2%Miss
TVRDTvardi Therapeutics, Inc.
Buy$5.00Apr 2024−47.2%Miss
TVRDTvardi Therapeutics, Inc.
Buy$5.00Mar 2024−53.1%Miss
ANNXAnnexon Inc
Buy$16.00Mar 2024−68.5%Miss
TVRDTvardi Therapeutics, Inc.
Buy$5.00Mar 2024−66.3%Miss
TVRDTvardi Therapeutics, Inc.
Buy$5.00Jan 2024−36.2%Miss
TVRDTvardi Therapeutics, Inc.
Buy$6.00Dec 2023−64.3%Miss
TVRDTvardi Therapeutics, Inc.
Buy$22.00Aug 2023−98.6%Miss
TVRDTvardi Therapeutics, Inc.
Buy$22.00May 2023−95.3%Miss
TVRDTvardi Therapeutics, Inc.
Buy$22.00Apr 2023−87.6%Miss
TVRDTvardi Therapeutics, Inc.
Buy$22.00Apr 2023−90.7%Miss
Go to

Joseph Stringer: analyst track record FAQ

Is Joseph Stringer a good stock analyst?

Yes, by track record. Joseph Stringer ranks number 151 of 347 of the analysts Bullish Whales scores, with a BW Score of 35 out of 100. Past results do not guarantee future ones.

What is Joseph Stringer's win rate?

Joseph Stringer's win rate is 35%. Across 53 scored calls, their rated stocks beat their sector 35% of the time over the next 12 months. On a typical call they returned −4.9% more than the sector.

What stocks and sectors does Joseph Stringer cover?

Joseph Stringer covers 7 companies, with the most coverage in Healthcare. See the ratings table above for every scored call and its outcome.

Are Joseph Stringer's price targets accurate?

Joseph Stringer's price targets are reached within 12 months 21% of the time. The base rate across all analysts Bullish Whales tracks is about 43 percent.

How accurate are Wall Street analyst price targets?

Most analyst price targets are not reached on schedule. Across every target Bullish Whales scores, the stock reaches the target within 12 months only about 43 percent of the time, which is why it helps to compare hit rates analyst by analyst.

Should I follow Joseph Stringer's stock ratings?

Their track record is strong, but no analyst is right every time. Follow the long-term track record rather than any single rating, size your positions to your own risk, and treat this as research, not investment advice.

How does Bullish Whales score analyst accuracy?

Bullish Whales scores every rating on real prices. We enter at the closing price on or after the call date, with no look-ahead, then measure the 12-month return above the stock's sector ETF and check whether the price target was reached. Scores are pulled toward the population average and corrected for testing thousands of analysts at once, so they reflect repeatable skill rather than luck.

How does Joseph Stringer rank among Wall Street analysts?

Joseph Stringer ranks number 151 of 347 by BW Score. We rank analysts by their realized 12-month sector-excess return and require a minimum number of calls so a few lucky picks cannot reach the top.

Browse the full analyst leaderboardHow analyst accuracy is scored

Every score, Win %, PT Hit % and rank is an estimate Bullish Whales calculates from its own data and may not be 100% accurate or complete. Returns are measured in excess of each rated stock's own sector over the 12 months after each call. Past performance does not guarantee future results, and nothing here is a recommendation to buy or sell any security.

v1.0.30